These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21730016)

  • 1. Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior.
    Gowin JL; Green CE; Alcorn JL; Swann AC; Moeller FG; Lane SD
    J Psychopharmacol; 2012 Jul; 26(7):982-93. PubMed ID: 21730016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute tiagabine administration on aggressive responses of adult male parolees.
    Lieving LM; Cherek DR; Lane SD; Tcheremissine OV; Nouvion SO
    J Psychopharmacol; 2008 Mar; 22(2):144-52. PubMed ID: 17715212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects.
    Paparrigopoulos T; Tzavellas E; Karaiskos D; Malitas P; Liappas I
    J Psychopharmacol; 2010 Sep; 24(9):1375-80. PubMed ID: 19346278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior.
    Lane SD; Gowin JL; Green CE; Steinberg JL; Moeller F; Cherek DR
    Pharmacol Biochem Behav; 2009 Apr; 92(2):357-62. PubMed ID: 19353809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.
    Pollack MH; Roy-Byrne PP; Van Ameringen M; Snyder H; Brown C; Ondrasik J; Rickels K
    J Clin Psychiatry; 2005 Nov; 66(11):1401-8. PubMed ID: 16420077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label study of tiagabine in panic disorder.
    Sheehan DV; Sheehan KH; Raj BA; Janavs J
    Psychopharmacol Bull; 2007; 40(3):32-40. PubMed ID: 18007567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of phenytoin on impulsive and premeditated aggression: a controlled study.
    Barratt ES; Stanford MS; Felthous AR; Kent TA
    J Clin Psychopharmacol; 1997 Oct; 17(5):341-9. PubMed ID: 9315984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician.
    Schmidt D; Gram L; Brodie M; Krämer G; Perucca E; Kälviäinen R; Elger CE
    Epilepsy Res; 2000 Oct; 41(3):245-51. PubMed ID: 10962215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tiagabine and non-convulsive status epilepticus].
    Holtkamp M; Pfeiffer M; Buchheim K; Meierkord H
    Nervenarzt; 1999 Dec; 70(12):1104-6. PubMed ID: 10637817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of tiagabine: summary of 53 trials.
    Leppik IE; Gram L; Deaton R; Sommerville KW
    Epilepsy Res; 1999 Feb; 33(2-3):235-46. PubMed ID: 10094434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
    Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
    Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group.
    Sachdeo RC; Leroy RF; Krauss GL; Drake ME; Green PM; Leppik IE; Shu VS; Ringham GL; Sommerville KW
    Arch Neurol; 1997 May; 54(5):595-601. PubMed ID: 9152116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological effects of tiagabine, a potential new antiepileptic drug.
    Sveinbjornsdottir S; Sander JW; Patsalos PN; Upton D; Thompson PJ; Duncan JS
    Seizure; 1994 Mar; 3(1):29-35. PubMed ID: 8044451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy.
    Dodrill CB; Arnett JL; Sommerville KW; Shu V
    Neurology; 1997 Apr; 48(4):1025-31. PubMed ID: 9109894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiagabine and non-convulsive status epilepticus.
    Schapel G; Chadwick D
    Seizure; 1996 Jun; 5(2):153-6. PubMed ID: 8795133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
    Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K
    Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced nonconvulsive status epilepticus with low dose of tiagabine.
    Fitzek S; Hegemann S; Sauner D; Bönsch D; Fitzek C
    Epileptic Disord; 2001 Sep; 3(3):147-50. PubMed ID: 11679307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.
    Uthman BM; Rowan AJ; Ahmann PA; Leppik IE; Schachter SC; Sommerville KW; Shu V
    Arch Neurol; 1998 Jan; 55(1):56-62. PubMed ID: 9443711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder.
    Alcorn JL; Gowin JL; Green CE; Swann AC; Moeller FG; Lane SD
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):229-32. PubMed ID: 24026715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study.
    Roth T; Wright KP; Walsh J
    Sleep; 2006 Mar; 29(3):335-41. PubMed ID: 16553019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.